FDA Targets Illegal Website Sales of Tramadol
website selling tramadol

FDA Targets Illegal Website Sales of Tramadol

  • Post author:
  • Post category:U.S. government
  • Reading time:3 min(s) read

The US Food and Drug Administration has issued a warning to website operators for the illegal sales of the opioid Tramadol. According to the letters sent to operators, some of the drugs were mislabeled, while others were not approved for sale in the United States. All of the websites are illicit and selling opioids without prescriptions.

FDA Cracking Down 0n Tramadol

While it may seem to be a minor way censure to have an FDA letter sent to a website, it’s the first action the agency typically takes. The FDA’s letter also clearly states that they are taking action, which means the letter is the first step.

The FDA’s primary job is to make sure that our foods and drugs stay safe. They do not have the authority to arrest website operators. However, they often bring the DEA and other …

Continue Reading FDA Targets Illegal Website Sales of Tramadol

Protesters Deliver Outgoing FDA Commissioner an 800lb “Heroin Spoon”

  • Post author:
  • Post category:fda / OxyContin
  • Reading time:2 min(s) read

Protestors descended on the FDA today to mark the end of Scott Gottlieb’s tenure with the delivery of a large “heroin spoon” sculpture stamped with the FDA’s logo. Activists say they are angry that the outgoing commissioner rubber-stamped Dsuvia, an incredibly powerful opioid that is meant for surgeries and late-term terminal cancer.

The group of activists urged the FDA to stop approving “dangerous” opioids and to focus on more ideas for medication-assisted treatment and other drugs to help treat addiction.

Dsuvia is a sublingual formulation of sufentanil, which is 500 times as powerful as morphine. The drugmaker says that the drug was created for the management of acute pain in adults in medically supervised healthcare settings. Activists and addiction specialist believe that the drug will eventually make it onto the street, causing overdose deaths, just like fentanyl. Fentanyl was developed …

Continue Reading Protesters Deliver Outgoing FDA Commissioner an 800lb “Heroin Spoon”

Smaller Pill Packs a Priority for FDA

President Donald Trump is planning on signing bipartisan bill H.R. 6 into law next week. When this happens, the new legislation will be going into effect the week of October 22, according to Scott Gottlieb, the FDA commissioner, who recently spoke at a Politico event. The first thing his agency wants to tackle? Creating smaller pill packaging for opioids, in hopes that it will prevent people from abusing their prescriptions for acute pain.

The legislation affects Purdue Pharma, Johnson & Johnson, and other large opioid manufacturers. It will force them to create new packaging for the drug to accommodate small quantities. The provision is an effort to prevent excess pills from being prescribed. With this policy, doctors may prescribe more limited amounts of pills. This could also prevent people from keeping leftover opioids around.

“The first thing that we’re …

Continue Reading Smaller Pill Packs a Priority for FDA

Oxycontin Manufacturer Helped Write the Laws it Claims Justify Marketing

Mired in lawsuits, Oxycontin manufacturer Perdue Pharma is quick to deflect blame when it comes to the opioid crisis. Marketing tactics such as paying doctors to do little more than discuss the drug with their colleagues and pushing the drug to ER physicians were all legal, according to the company. But is this reality, or are these the pleadings of a company that is watching its ship sink?

The truth is more complicated than that; it turns out. The FDA and Purdue Pharma have a close relationship, although until recently, the FDA may not have realized it. Purdue Pharma operatives were consulted when the FDA created policies that affect the entire nation, often getting the government agency to agree to policies and procedures that limit the manufacturer’s liability. However, the FDA officials didn’t realize that Perdue was paying the people …

Continue Reading Oxycontin Manufacturer Helped Write the Laws it Claims Justify Marketing

Is Kratom an Opioid? The FDA Says Yes

The Food and Drug Administration put out new warnings about kratom, saying that the drug is best classified as a substance with “opioid properties” and linking it to 44 deaths. Previously, the DEA took steps to outlaw the drug altogether but halted their actions as Kratom advocates led campaigns against the agency involving petitions and phone calls.

Kratom has become popular among people with opioid use disorder trying to get clean from heroin and other potent, addictive drugs. People with chronic pain, depression, and a myriad of other diseases. Often, sellers of Kratom market the drug in capsule, powder, and tea form. People claim it helps ease the symptoms of a wealth of diseases.

While these benefits sound great, there are many people in the addiction community that believe that replacing opioids with Kratom is a dangerous and unsustainable practice. …

Continue Reading Is Kratom an Opioid? The FDA Says Yes

Feds Crack Down on Illegal Online Pharmacies

Many prescription drug abusers have discovered how easy it is to use the Internet to obtain painkillers, stimulants and tranquilizers without a prescription. As part of an international crackdown on prescription drug abuse, the federal government has been taking action against online pharmacies that sell prescription drugs without requiring a prescription. In October, the U.S. Food and Drug Administration participated in a global effort to combat the online sale of illegal and counterfeit drugs. The effort, which was called Operation Pangea V, led to seizure of drugs valued at more $10 million and the shutdown of more than 18,000 illegal pharmacy websites.

 

Feds Target Google, FedEx and UPS

 

The U.S. Justice Department has targeted online pharmacies since 2005. The agency’s focus has recently moved beyond individual website operators to the service providers that have enabled drug sales and…
Continue Reading Feds Crack Down on Illegal Online Pharmacies

Doctors Petition for New Prescription Painkiller Rules to Limit Abuse

In an effort to protect the public from prescription drug abuse, a group of 37 doctors and public health officials have petitioned the U.S. Food and Drug Administration to change the prescription guidelines for opioid painkillers.

They have asked the FDA to change the labeling for drugs like OxyContin and Opana, prohibiting use of the drugs for treatment of moderate pain, adding a maximum daily dosage and specifying that patients should only take them for 90 days if not under treatment for cancer-related pain.

By changing the labels of these prescription drugs, the group hopes to limit promotion of the drugs for non-approved uses by drug makers like Purdue Pharma, Pfizer and Endo Health Solutions. OxyContin and Opana, which are both extended-release painkillers, are marketed by Purdue Pharma and Endo Health for the treatment of moderate pain to severe pain.…
Continue Reading Doctors Petition for New Prescription Painkiller Rules to Limit Abuse